Treatment

Panzyga 100 mg/ml Infusionslösung clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia (“PRO-SID” study).
This study is testing a new medicine called Panzyga to see if it can help prevent serious infections in people with a type of blood cancer called chronic lymphocytic leukaemia (CLL). It wants to find out if taking Panzyga reduces how often these infections happen.
For: Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia.
Hungary · Greece · Czechia
Ongoing, recruitingTherapeutic confirmatory (Phase III)
A superiority phase III study to compare the effect of Panzyga versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome
This study is testing a medicine called Panzyga for children with PANS, a condition causing sudden changes in their brain and behaviour. We want to see if Panzyga helps improve their symptoms better than a dummy treatment.
For: Pediatric acute-onset neuropsychiatric syndrome (PANS)
Sweden · Italy